News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
727,300 Results
Type
Article (64233)
Company Profile (446)
Press Release (662621)
Section
Business (207713)
Career Advice (2912)
Deals (36710)
Drug Delivery (98)
Drug Development (84460)
Employer Resources (176)
FDA (16971)
Job Trends (16013)
News (356219)
Policy (35581)
Tag
Academia (2947)
Africa (1003)
Alliances (52405)
Alzheimer's disease (1232)
Antibody-drug conjugate (ADC) (60)
Approvals (16907)
Arizona (143)
Artificial intelligence (74)
Asia (44032)
Australia (7425)
Bankruptcy (364)
Best Places to Work (11986)
Biosimilars (68)
Biotechnology (313)
C2C Services and Suppliers (83228)
California (1612)
Canada (841)
Cancer (369)
Career advice (2444)
Cell therapy (116)
China (116)
Clinical research (65360)
Collaboration (120)
Colorado (68)
Connecticut (67)
COVID-19 (2728)
Cystic fibrosis (76)
Data (128)
Diabetes (71)
Diagnostics (6383)
Drug pricing (76)
Earnings (79521)
Employer resources (151)
Europe (98738)
Events (109821)
Executive appointments (95)
FDA (17143)
Florida (213)
Funding (98)
Gene therapy (85)
GLP-1 (584)
Government (4790)
Healthcare (20233)
Hotbed/Location (482663)
Illinois (267)
Indiana (142)
Infectious disease (2755)
Inflammatory bowel disease (98)
Interviews (525)
IPO (16850)
Job creations (4126)
Job search strategy (2066)
Kansas (97)
Layoffs (451)
Legal (8564)
Lung cancer (83)
Manufacturing (84)
Maryland (368)
Massachusetts (1397)
Medical device (14148)
Medtech (14151)
Mergers & acquisitions (19654)
Metabolic disorders (252)
Michigan (125)
Minnesota (214)
Neuroscience (1356)
New Jersey (496)
New York (496)
NextGen Class of 2024 (7316)
Non-profit (4962)
North Carolina (650)
Northern California (712)
Obesity (158)
Ohio (100)
Opinion (224)
Patents (63)
Pennsylvania (521)
People (58812)
Pharmaceutical (93)
Phase I (20349)
Phase II (28751)
Phase III (21594)
Pipeline (93)
Postmarket research (2633)
Preclinical (8995)
Press Release (72)
Rare diseases (123)
Real estate (6481)
Recruiting (68)
Regulatory (23184)
Research institute (2606)
Resumes & cover letters (467)
South America (1366)
Southern California (639)
Startups (4003)
Texas (195)
United States (7787)
Vaccines (536)
Washington State (249)
Weight loss (148)
Date
Last 7 days (489)
Last 30 days (2285)
Last 365 days (39775)
2024 (26041)
2023 (42252)
2022 (53611)
2021 (58357)
2020 (57178)
2019 (50469)
2018 (38449)
2017 (35640)
2016 (35444)
2015 (41084)
2014 (33935)
2013 (29575)
2012 (31175)
2011 (31559)
2010 (29222)
727,300 Results for "universite libre de bruxelles".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioCapital
MCRA Supports Onkos Surgical with First FDA De Novo Approval for Antibacterial Coating for Implants
MCRA, the leading privately held independent medical device, diagnostics, and biologics Clinical Research Organization (CRO) and advisory firm is pleased to announce its role in the U.S. Food and Drug Administration’s (FDA) De Novo granting for Onkos Surgical’s antibacterial coating for tumor and revision orthopedic implants.
June 20, 2024
·
4 min read
Genetown
Insulet Announces CE Mark Approval of Omnipod® 5 Integration with Abbott FreeStyle Libre 2 Plus Sensor
Insulet Corporation announced it has received CE mark approval under the European Medical Device Regulation for the added compatibility of the Abbott FreeStyle Libre 2 Plus sensor with Insulet’s Omnipod 5 Automated Insulin Delivery System for individuals aged two years and older with type 1 diabetes.
February 7, 2024
·
4 min read
BioMidwest
Tandem Diabetes Care’s t:slim X2™ Insulin Pump is the First Automated Insulin Delivery System to Integrate with Abbott’s New FreeStyle Libre® 2 Plus Sensor
Tandem Diabetes Care’s t:slim X2 ™ Insulin Pump is the First Automated Insulin Delivery System to Integrate with Abbott’s New FreeStyle Libre ® 2 Plus Sensor.
January 8, 2024
·
10 min read
Biotech Bay
MedGenome announces de novo Genome Assembly and Annotation Grant winners for 2024
MedGenome, a global partner for comprehensive multiomics solutions, in collaboration with PacBio, is pleased to announce Dr. Lauren Esposito of the California Academy of Sciences as the recipient of the ‘2024 de novo genome assembly and annotation grant’.
May 2, 2024
·
4 min read
Business
Echosens Appoints Dr. Victor De Lédinghen as Chief Medical Officer
Echosens announced the appointment of Victor de Lédinghen, MD PhD, as the company’s new Chief Medical Officer.
March 26, 2024
·
2 min read
Press Releases
Haystack Oncology and Université de Montréal’s affiliated hospital research centre, the CRCHUM, to Deploy Haystack MRD™ Technology in Research Study for Metastatic Colorectal Cancer
July 29, 2024
·
5 min read
Biotech Bay
Injectsense First-in-Human Glaucoma Device Study Approved by Ethics Committee at Centro de la Vision Clinic
Injectsense Inc., a sensor-enabled digital health company, announced that the ethics committee at the Centro de la Vision Clinic in Santiago, Chile, has approved a 20-patient study that will confirm safety and effectiveness of the company’s ultra-miniature wireless pressure sensor, designed to continuously measure intra-ocular pressure (IOP) for glaucoma.
May 6, 2024
·
4 min read
Pharm Country
Onkos Surgical Announces First FDA De Novo Approval of an Antibacterial Coating for Tumor and Revision Orthopaedic Implants
Onkos Surgical, an orthopaedic company founded to address the complex clinical challenges associated with bone loss due to tumor, trauma, and revision surgery, announced that the U.S. Food & Drug Administration (FDA) granted the company a De Novo approval for its novel antibacterial coated implants.
April 8, 2024
·
4 min read
BioForest
Key Proteo Submits De Novo Application to FDA for its First Newborn Screening Kit
Key Proteo, a pioneering proteomics diagnostics company specializing in the enhanced early detection of rare but treatable genetic disorders, today announced that it has submitted a de novo classification request to the U.S. Food and Drug Administration (FDA) for its first in vitro diagnostic Key Proteo Newborn Screening Kit.
March 29, 2024
·
5 min read
Antonin (Tony) de Fougerolles appointed as new Chair of etherna
July 10, 2024
·
3 min read
1 of 72,730
Next